Travere Therapeutics, Inc. — SCHEDULE 13G/A Filings
18 SCHEDULE 13G/A filings on record
This page lists all SCHEDULE 13G/A filings submitted to the SEC by Travere Therapeutics, Inc. (TVTX), sorted by most recent first. Each row links to the full filing on EdgarLookup. Travere Therapeutics, Inc. has filed 18 SCHEDULE 13G/A documents with the SEC since 2014. To view all SEC filings by Travere Therapeutics, Inc., see the full filings list.
All
10-12G
10-12G/A
10-K
10-K/A
10-Q
10-Q/A
144
3
3/A
305B2
4
4/A
424B1
424B3
424B5
5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
EFFECT
FWP
NT 10-K
NT 10-Q
PRE 14A
RW
S-1
S-1/A
S-3
S-3/A
S-3ASR
S-3MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC 14F1
SC 14F1/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-002431 | Mar 27, 2026 | — |
| SCHEDULE 13G/A | — | 0001172661-26-001227 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001193125-26-054520 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001193125-26-049707 | Feb 13, 2026 | — |
| SCHEDULE 13G/A | — | 0001172661-25-005160 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001172661-25-003635 | Aug 15, 2025 | — |
| SCHEDULE 13G/A | — | 0000932471-25-001051 | Jul 29, 2025 | — |
| SCHEDULE 13G/A | — | 0000950170-25-071930 | May 15, 2025 | — |
| SCHEDULE 13G/A | — | 0001172661-25-002216 | May 15, 2025 | — |
| SCHEDULE 13G/A | — | 0001172661-25-002075 | May 15, 2025 | — |
| SCHEDULE 13G/A | — | 0000932471-25-000623 | Apr 30, 2025 | — |
| SCHEDULE 13G/A | — | 0001576419-25-000661 | Apr 17, 2025 | — |
| SCHEDULE 13G/A | — | 0001172661-25-001271 | Feb 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-001022 | Feb 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001172661-25-000906 | Feb 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000950170-25-015862 | Feb 7, 2025 | — |
| SCHEDULE 13G/A | — | 0002012383-25-001251 | Feb 5, 2025 | — |
| SCHEDULE 13G/A | — | 0000932471-25-000267 | Jan 31, 2025 | — |